TENON MEDICAL INC (TNON) Stock Analyst Earnings Estimates
NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 160K 300.00% | 690K 331.25% | 2.928M 324.35% | 3.778M 29.03% | 7.567M 100.29% | 9.228M 21.95% | |
| EBITDA YoY % growth | -6.46M | -18.65M -188.70% | -15.528M 16.74% | N/A | N/A | N/A | |
| EBIT YoY % growth | -6.46M -1,096.30% | -18.73M -189.94% | -15.727M 16.03% | -14.419M 8.32% | -14.187M 1.61% | -13.002M 8.35% | |
| Operating Margin | -4,037.50% | -2,714.49% | -537.12% | -381.65% | -187.48% | -140.90% | |
| EPS YoY % growth | N/A | N/A | -77.92 59.71% | -16.88 78.34% | -8.03 52.42% | -6.72 16.32% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.59 52.38% | -2.81 71.90% | -2.61 68.00% | -1.68 53.64% | -1.56 39.76% |
| Revenue Q2Q % growth | 1.48M 83.17% | 1.497M 108.21% | 1.64M 82.02% | 1.857M 109.36% | 2.573M 73.85% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.475M -10.64% | -3.754M -7.08% | -3.654M 5.64% | -3.491M -8.58% | -3.288M 5.39% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -3.63 68.92% | -4.32 | 0.69 | 15.97% |
| Q2 2024 Q2Q % growth | -8.16 69.09% | -8.85 | 0.69 | 7.83% |
| Q1 2024 Q2Q % growth | -10.00 70.93% | -10.93 | 0.93 | 8.55% |
| Q4 2023 Q2Q % growth | -5.44 90.29% | -11.26 | 5.82 | 51.69% |
| Q3 2023 Q2Q % growth | -11.68 47.86% | -22.85 | 11.17 | 48.88% |
| Q2 2023 Q2Q % growth | -26.40 49.23% | -31.01 | 4.61 | 14.86% |
| Q1 2023 Q2Q % growth | -34.40 | -30.19 | -4.21 | -13.94% |
| Q4 2022 Q2Q % growth | -56.00 | -57.12 | 1.12 | 1.96% |
| Q3 2022 Q2Q % growth | -22.40 | -38.35 | 15.95 | 41.59% |
| Q2 2022 Q2Q % growth | -52.00 | -16.32 | -35.68 | -218.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 887K -6.04% | 1.214M | -327K | -26.94% |
| Q2 2024 Q2Q % growth | 901K 21.27% | 927.69K | -26.69K | -2.88% |
| Q1 2024 Q2Q % growth | 719K 66.05% | 798.66K | -79.66K | -9.97% |
| Q4 2023 Q2Q % growth | 808K 188.57% | 1.084M | -276K | -25.46% |
| Q3 2023 Q2Q % growth | 944K 349.52% | 1.093M | -149K | -13.63% |
| Q2 2023 Q2Q % growth | 743K 430.71% | 1.02M | -277K | -27.16% |
| Q1 2023 Q2Q % growth | 433K 518.57% | 467.16K | -34.16K | -7.31% |
| Q4 2022 Q2Q % growth | 280K 460.00% | 282.54K | -2.54K | -0.90% |
| Q3 2022 Q2Q % growth | 210K 200.00% | 289.68K | -79.68K | -27.51% |
| Q2 2022 Q2Q % growth | 140K 275.34% | 144.84K | -4.84K | -3.34% |
| Q4 2021 Q2Q % growth | 50K 400.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -268.12% | 0% | 14.45% |
| Revenue | 0% | -10.57% | 0% | -14.6% |